At the close of business on 7 May 2021, Morten Opstad, Chair of the Board of
IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose
of the Extraordinary General Meeting on 12 May 2021:
Total 265,001,021 shares or 28,91% of the share capital and votes, consisting of
the following:
* Proxy to present and vote for 164,454,707 shares or 17,94% of the share
capital, including shares held by Mr Opstad and close relations
* Proxy with voting instructions for 100,546,314 shares or 10,97% of the share
capital.
For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=oK5zwNtRsZ1s5umKWlj0gvhxK4PRPMGHg8q9
WpY79SVXH4zYq--0sgcQP_Odo0-K69jgeZX2OpVVepCuqIf4kSf6qGBkxSGU_Vjk3s4scM-PtiXZkVss
8JPP0gq8wLKP)
Tel: + 47 918 00186
Brett L Perry, U.S. Investor Relations
E-mail: bperry@sheltongroup.com (mailto:bperry@sheltongroup.com)
Tel: + 1 214 272 0070
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDXBA) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
touch-free authentication for all. We help people make payments, prove their
identity, gain access to information, unlock devices or gain admittance to
buildings. We invent, engineer, and commercialize these secure and safe yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics.
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.